Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 401
Selected: 0
NCT IDTitle
NCT00004865Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy
NCT03582774Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical Prostatectomy
NCT00004050Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer
NCT05688215Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
NCT00005024Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease
NCT05000359A Mobile Phone Intervention to Promote Adherence to Survivorship Care Among Adolescent and Young Adult Cancer Survivors
NCT07461948Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients
NCT00039325Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma
NCT01144247Cellular Immunotherapy Study for Brain Cancer
NCT00040950Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT00066508Bortezomib in Treating Patients With Diffuse Large B-Cell Lymphoma That Is Refractory To Chemotherapy
NCT07671768Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Tumors, ONE SHOT Trial
NCT02688348Quality of Life After Bladder-Preservation Chemotherapy and Radiation Therapy in Patients With Muscle-Invasive Bladder Cancer
NCT00024076Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer
NCT00910650Study of Gene Modified Immune Cells in Patients With Advanced Melanoma
NCT00015860STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic Leukemia
NCT00003410Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas
NCT0492882068Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy
NCT01826864Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II Melanoma
NCT02775292Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1
NCT01059513Hypo-fractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer
NCT00072059Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT06448286PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma
NCT00039273Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer
NCT00093548Vaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver Cancer
NCT00138164Denileukin Diftitox in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT00020878Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers
NCT00253617Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery
NCT00005084Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade Astrocytoma
NCT01005472Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma
NCT00093730BMS-599626 in Treating Patients With Metastatic Solid Tumors
NCT00020865Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia
NCT03503643Hemi-Gland Cryoablation for Prostate Cancer at UCLA
NCT04069910Stereotactic Radiation Therapy Before Surgery for the Treatment of Resectable Brain Metastases
NCT01180868The Biodistribution of 1-L-(2 Deoxy-2,- 18 Fluoroarabinofuranosyl) Cytosine ([18F]L-FAC) in Healthy Subjects and Patients With Cancer, Autoimmune and Inflammatory Diseases
NCT00790595Clinical Study of SU011248 in Subjects With High Risk Prostate Cancer Who Have Elected to Undergo Radical Prostatectomy
NCT00004881Vaccine Therapy in Treating Patients With Advanced Cancer
NCT04457245Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer
NCT0485750299mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer
NCT06538337Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers
NCT02597894Targeted Biopsies in Determining Response in Patients With Prostate Cancer Undergoing High-Dose-Rate Brachytherapy
NCT04384770CT-guided Stereotactic Body Radiation Therapy and MRI-guided Stereotactic Body Radiation Therapy for Prostate Cancer, MIRAGE Study
NCT00093769Bortezomib and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
NCT06216249Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)
NCT02235116Predictors of Patient Attitudes and Barriers to Skin Cancer Screening
NCT05558904An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer
NCT0405021568GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer
NCT00004878Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia
NCT00255749Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer
NCT05523700Value-based Integrated Recommendation Software Guiding Ovarian Cancer Treatment (VIRGO2)